2. Academic Validation
  3. Synthetic lethality of mRNA quality control complexes in cancer

Synthetic lethality of mRNA quality control complexes in cancer

  • Nature. 2025 Feb 5. doi: 10.1038/s41586-024-08398-6.
Vivian Prindle # 1,  Adam E Richardson # 1,  Kimberly R Sher # 1,  Sarah Kongpachith 2,  Kaitlin Kentala 1,  Sakina Petiwala 1,  Dong Cheng 1,  Deborah Widomski 1,  Phuong Le 1,  Maricel Torrent 1,  Anlu Chen 2,  Stephen Walker 1,  Marianne B Palczewski 1,  Diya Mitra 1,  Vlasios Manaves 1,  Xu Shi 2,  Charles Lu 1,  Stephanie Sandoval 1,  Zoltan Dezso 2,  F Gregory Buchanan 1,  Daniel Verduzco 1,  Brian Bierie 1,  Jonathan A Meulbroek 1,  William N Pappano 1,  Joshua P Plotnik 3
Affiliations

Affiliations

  • 1 AbbVie, North Chicago, IL, USA.
  • 2 AbbVie Bay Area, South San Francisco, CA, USA.
  • 3 AbbVie, North Chicago, IL, USA. joshua.plotnik@abbvie.com.
  • # Contributed equally.
PMID: 39910291 DOI: 10.1038/s41586-024-08398-6
Abstract

Synthetic lethality exploits the genetic vulnerabilities of Cancer cells to enable a targeted, precision approach to treat Cancer1. Over the past 15 years, synthetic lethal Cancer target discovery approaches have led to clinical successes of PARP inhibitors2 and ushered several next-generation therapeutic targets such as WRN3, USP14, PKMYT15, POLQ6 and PRMT57 into the clinic. Here we identify, in human Cancer, a novel synthetic lethal interaction between the PELO-HBS1L and SKI complexes of the mRNA quality control pathway. In distinct genetic contexts, including 9p21.3-deleted and high microsatellite instability (MSI-H) tumours, we found that phenotypically destabilized SKI complex leads to dependence on the PELO-HBS1L ribosomal rescue complex. PELO-HBS1L and SKI complex synthetic lethality alters the normal cell cycle and drives the unfolded protein response through the activation of IRE1, as well as robust tumour growth inhibition. Our results indicate that PELO and HBS1L represent novel therapeutic targets whose dependence converges upon SKI complex destabilization, a common phenotypic biomarker in diverse genetic contexts representing a significant population of patients with Cancer.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z